Preeclampsia and low sodium: A retrospective cohort analysis and literature review.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 04 05 2020
revised: 18 12 2020
accepted: 26 12 2020
pubmed: 10 1 2021
medline: 25 9 2021
entrez: 9 1 2021
Statut: ppublish

Résumé

The aim of this study was to retrospectively analyze the prevalence of severe preeclampsia and low sodium (PALS) among the pregnant population admitted at the University Hospital of Udine in the past 4 years and to compare these data with the current literature. Only women with a diagnosis of preeclampsia were included. According to the lowest sodium level measured either 5 days before or 5 days after delivery, patients were divided in two groups: women with hyponatremia (<135 mmol/L; severe <120 mmol/L) and women with normonatremia (>135 mmol/L). Moreover, a search literature was performed. Of 59 patients with preeclampsia, 20 (34%) had hyponatremia. Only one case (1.6%) of severe maternal hyponatremia (sodium level 117 mmol/L) in the setting of preeclampsia was identified. After literature search, a total of 22 manuscripts including 60 case reports of PALS were identified. The lowest sodium level was 113 mmol/L, at 25 weeks of gestation. In most cases hyponatremia was treated with fluid restriction. In only 5 cases hyponatremia was treated with a saline hypertonic solution. Hyponatremia resolution, when reported, occurred in about 48 h. Sodium level in neonates ranged from 118 and 128 mmol/L. PALS may occur in about a third of women with severe preeclampsia. Severe maternal hyponatremia should be treated with fluid restriction and with hypertonic saline solution. Moreover neonatologists should be alerted in order to treat the neonate for the best outcome.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to retrospectively analyze the prevalence of severe preeclampsia and low sodium (PALS) among the pregnant population admitted at the University Hospital of Udine in the past 4 years and to compare these data with the current literature.
METHODS METHODS
Only women with a diagnosis of preeclampsia were included. According to the lowest sodium level measured either 5 days before or 5 days after delivery, patients were divided in two groups: women with hyponatremia (<135 mmol/L; severe <120 mmol/L) and women with normonatremia (>135 mmol/L). Moreover, a search literature was performed.
RESULTS RESULTS
Of 59 patients with preeclampsia, 20 (34%) had hyponatremia. Only one case (1.6%) of severe maternal hyponatremia (sodium level 117 mmol/L) in the setting of preeclampsia was identified. After literature search, a total of 22 manuscripts including 60 case reports of PALS were identified. The lowest sodium level was 113 mmol/L, at 25 weeks of gestation. In most cases hyponatremia was treated with fluid restriction. In only 5 cases hyponatremia was treated with a saline hypertonic solution. Hyponatremia resolution, when reported, occurred in about 48 h. Sodium level in neonates ranged from 118 and 128 mmol/L.
CONCLUSIONS CONCLUSIONS
PALS may occur in about a third of women with severe preeclampsia. Severe maternal hyponatremia should be treated with fluid restriction and with hypertonic saline solution. Moreover neonatologists should be alerted in order to treat the neonate for the best outcome.

Identifiants

pubmed: 33421847
pii: S2210-7789(20)30167-7
doi: 10.1016/j.preghy.2020.12.007
pii:
doi:

Substances chimiques

Saline Solution, Hypertonic 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-173

Informations de copyright

Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Auteurs

Serena Xodo (S)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy. Electronic address: serenaxodo@yahoo.it.

Fabiana Cecchini (F)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Lisa Celante (L)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Alice Novak (A)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Emma Rossetti (E)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Giovanni Baccarini (G)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Ambrogio Pietro Londero (AP)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Lorenza Driul (L)

Department of Gynecology and Obstetrics, School of Medicine of Udine, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH